Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 3
2008 1
2009 1
2010 1
2011 2
2012 1
2013 1
2014 1
2015 1
2016 2
2017 1
2018 2
2019 3
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB.
Schelker RC, Andrulis M, Müller G, Ushmorov A, Hart C, Herr W, Vogelhuber M, Iberl S, Grassinger J. Schelker RC, et al. Among authors: grassinger j. Blood Cells Mol Dis. 2019 May;76:78-81. doi: 10.1016/j.bcmd.2019.02.005. Epub 2019 Feb 20. Blood Cells Mol Dis. 2019. PMID: 30827761 No abstract available.
Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.
Johannesen S, Budeus B, Peters S, Iberl S, Meyer AL, Kammermaier T, Wirkert E, Bruun TH, Samara VC, Schulte-Mattler W, Herr W, Schneider A, Grassinger J, Bogdahn U. Johannesen S, et al. Among authors: grassinger j. Front Neurol. 2018 Nov 26;9:971. doi: 10.3389/fneur.2018.00971. eCollection 2018. Front Neurol. 2018. PMID: 30534107 Free PMC article.
Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis.
Johannesen S, Huie JR, Budeus B, Peters S, Wirth AM, Iberl S, Kammermaier T, Kobor I, Wirkert E, Küspert S, Tahedl M, Grassinger J, Pukrop T, Schneider A, Aigner L, Schulte-Mattler W, Schuierer G, Koch W, Bruun TH, Ferguson AR, Bogdahn U. Johannesen S, et al. Among authors: grassinger j. Front Neurol. 2021 Mar 18;12:616289. doi: 10.3389/fneur.2021.616289. eCollection 2021. Front Neurol. 2021. PMID: 33815246 Free PMC article.
The relationship between bone, hemopoietic stem cells, and vasculature.
Ellis SL, Grassinger J, Jones A, Borg J, Camenisch T, Haylock D, Bertoncello I, Nilsson SK. Ellis SL, et al. Among authors: grassinger j. Blood. 2011 Aug 11;118(6):1516-24. doi: 10.1182/blood-2010-08-303800. Epub 2011 Jun 14. Blood. 2011. PMID: 21673348 Free article.
The role of Tenascin C in the lymphoid progenitor cell niche.
Ellis SL, Heazlewood SY, Williams B, Reitsma AJ, Grassinger J, Borg J, Heazlewood CK, Chidgey AP, Nilsson SK. Ellis SL, et al. Among authors: grassinger j. Exp Hematol. 2013 Dec;41(12):1050-61. doi: 10.1016/j.exphem.2013.09.009. Epub 2013 Sep 29. Exp Hematol. 2013. PMID: 24084079 Free article.
Diagnostic Value of Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) for the Pre-Therapeutic Loco-Regional Staging of Cervical Cancer: A Feasibility and Interobserver Reliability Study.
Schleder S, May M, Scholz C, Dinkel J, Strotzer Q, Einspieler I, Dollinger M, Schreyer AG, Grassinger J, Schicho A. Schleder S, et al. Among authors: grassinger j. Curr Oncol. 2023 Jan 13;30(1):1164-1173. doi: 10.3390/curroncol30010089. Curr Oncol. 2023. PMID: 36661738 Free PMC article.
25 results